Mark Coles

10.3k total citations · 2 hit papers
127 papers, 5.9k citations indexed

About

Mark Coles is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Coles has authored 127 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 33 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Mark Coles's work include Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (34 papers) and Immunotherapy and Immune Responses (30 papers). Mark Coles is often cited by papers focused on Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (34 papers) and Immunotherapy and Immune Responses (30 papers). Mark Coles collaborates with scholars based in United Kingdom, United States and Switzerland. Mark Coles's co-authors include David H. Raulet, Dimitris Kioussis, Henrique Veiga‐Fernandes, Jasper de Boer, Trisha Norton, Paul M. Kaye, Christopher D. Buckley, Adam Williams, Kathleen Roderick and Mauro Tolaini and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark Coles

123 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

2003 582 citations Mark Coles, Trisha Norton et al. profile →
Fibroblasts as immune regulators in infection, inflammation and cancer

2021 365 citations Sarah Davidson, Mark Coles et al. Nature reviews. Immunology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Coles	3.5k	1.4k	1.2k	613	376	127	5.9k
Rimpei Morita	4.3k 1.2×	1.7k 1.2×	1.1k 0.9×	476 0.8×	218 0.6×	84	6.7k
Scott D. Boyd	3.2k 0.9×	2.2k 1.6×	1.1k 0.9×	358 0.6×	258 0.7×	119	6.7k
Guttorm Haraldsen	4.4k 1.2×	1.6k 1.1×	1.6k 1.3×	1.3k 2.1×	357 0.9×	89	7.2k
Jens V. Stein	3.2k 0.9×	1.6k 1.2×	1.4k 1.2×	320 0.5×	227 0.6×	102	5.6k
Ryuji Suzuki	2.1k 0.6×	929 0.7×	984 0.8×	421 0.7×	389 1.0×	160	4.9k
Tri Giang Phan	3.7k 1.0×	1.4k 1.0×	946 0.8×	307 0.5×	210 0.6×	66	5.9k
Adeeb Rahman	2.3k 0.7×	1.4k 1.0×	893 0.8×	309 0.5×	218 0.6×	79	4.2k
Marc Beyer	3.4k 1.0×	1.8k 1.3×	1.2k 1.0×	216 0.4×	316 0.8×	129	6.2k
Eric J. Kunkel	4.4k 1.2×	1.6k 1.2×	1.6k 1.3×	269 0.4×	472 1.3×	48	7.1k
Naomi Taylor	2.0k 0.6×	1.4k 1.0×	1.4k 1.2×	384 0.6×	327 0.9×	104	4.6k

Countries citing papers authored by Mark Coles

Since Specialization

Citations

This map shows the geographic impact of Mark Coles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Coles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Coles more than expected).

Fields of papers citing papers by Mark Coles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Coles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Coles. The network helps show where Mark Coles may publish in the future.

Co-authorship network of co-authors of Mark Coles

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Coles. A scholar is included among the top collaborators of Mark Coles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Coles. Mark Coles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cowan, Morton J., Sarah Davidson, Mark Coles, & Christopher D. Buckley. (2025). The Role of Fibroblasts Across Inflammation and Immunity. Annual Review of Pathology Mechanisms of Disease. 21(1). 423–445.

Ridley, Anna, Mathew Baldwin, Christopher D. Buckley, et al.. (2023). Cellular characterisation of advanced osteoarthritis knee synovium. Arthritis Research & Therapy. 25(1). 154–154. 11 indexed citations

Parent, Éric, et al.. (2023). Inventory of Patient-Reported Outcome Measures Used in the Non-Operative Care of Scoliosis: A Scoping Review. Children. 10(2). 239–239. 4 indexed citations

Davidson, Sarah, Mark Coles, Tom Thomas, et al.. (2021). Fibroblasts as immune regulators in infection, inflammation and cancer. Nature reviews. Immunology. 21(11). 704–717. 365 indexed citations breakdown →

Ye, Weiyu, Anna Olsson‐Brown, Robert Watson, et al.. (2021). Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British Journal of Cancer. 124(10). 1661–1669. 33 indexed citations

Aschenbrenner, Dominik, Maria Quaranta, Soumya Banerjee, et al.. (2020). Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 70(6). 1023–1036. 68 indexed citations

Nayar, Saba, Joana Campos, Charlotte G. Smith, et al.. (2019). Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology. Proceedings of the National Academy of Sciences. 116(27). 13490–13497. 138 indexed citations

Alden, Kieran, Margherita Coccia, Aurélie Chalon, et al.. (2019). Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action. Frontiers in Immunology. 10. 2150–2150. 5 indexed citations

Colas, J., Ian S. Hitchcock, Mark Coles, Steven Johnson, & Thomas F. Krauss. (2018). Quantifying single-cell secretion in real time using resonant hyperspectral imaging. Proceedings of the National Academy of Sciences. 115(52). 13204–13209. 30 indexed citations

10.

Pandey, S., Frédéric Mourcin, Tony Marchand, et al.. (2017). IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma. Blood. 129(18). 2507–2518. 67 indexed citations

11.

Butler, James A., et al.. (2016). Imaging Immunity in Lymph Nodes: Past, Present and Future. Advances in experimental medicine and biology. 915. 329–346. 5 indexed citations

12.

Alden, Kieran, Jon Timmis, & Mark Coles. (2014). Easing Parameter Sensitivity Analysis of Netlogo Simulations Using SPARTAN. 622–628. 1 indexed citations

13.

Maroof, Asher, Lynette Beattie, Alun C. Kirby, Mark Coles, & Paul M. Kaye. (2009). Dendritic Cells Matured by Inflammation Induce CD86-Dependent Priming of Naive CD8+ T Cells in the Absence of Their Cognate Peptide Antigen. The Journal of Immunology. 183(11). 7095–7103. 18 indexed citations

14.

Foster, Katie, Julie M. Sheridan, Henrique Veiga‐Fernandes, et al.. (2008). Contribution of Neural Crest-Derived Cells in the Embryonic and Adult Thymus. The Journal of Immunology. 180(5). 3183–3189. 135 indexed citations

15.

Jamieson, A. M., et al.. (2004). Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions. The Journal of Immunology. 172(2). 864–870. 132 indexed citations

16.

Garefalaki, Anna, Mark Coles, Georgia Mavria, et al.. (2002). Variegated Expression of CD8α Resulting from In Situ Deletion of Regulatory Sequences. Immunity. 16(5). 635–647. 44 indexed citations

17.

Wack, Andreas, Mark Coles, Trisha Norton, Arnd Hostert, & Dimitris Kioussis. (2000). Early Onset of CD8 Transgene Expression Inhibits the Transition from DN3 to DP Thymocytes. The Journal of Immunology. 165(3). 1236–1242. 11 indexed citations

18.

Coles, Mark & David H. Raulet. (2000). NK1.1+ T Cells in the Liver Arise in the Thymus and Are Selected by Interactions with Class I Molecules on CD4+CD8+ Cells. The Journal of Immunology. 164(5). 2412–2418. 174 indexed citations

19.

Coles, Mark & David H. Raulet. (1994). Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes.. The Journal of Experimental Medicine. 180(1). 395–399. 143 indexed citations

20.

Bix, Mark, Mark Coles, & David H. Raulet. (1993). Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells.. The Journal of Experimental Medicine. 178(3). 901–908. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact